Search for Clinical Trial Results

Mucopolysaccharidosis Type I - 127 Studies Found
Status | Study |
Enrolling by invitation |
Study Name: Immunodeficiency in Cartilage-hair Hypoplasia: Sub-project on Safety of Vaccination Against Chickenpox Condition: Date: 2023-12-10 |
Recruiting |
Study Name: A Study of JR-141 in Patients With Mucopolysaccharidosis Type II Condition: Mucopolysaccharidosis II Date: 2017-04-10 Interventions: Drug: JR-141 IV infusion (lyophilized powder), 0.01-2.0 mg/kg/week |
Recruiting |
Study Name: Safety and Dose Ranging Study of Insulin Receptor MoAb-IDS Fusion Protein in Patients With Hunter Syndrome Condition: Date: 2023-12-10 |
Completed |
Study Name: To Evaluate the Safety and Efficacy of GC1111 (Recombinant Human Iduronate-2-sulfatase) in Hunter Syndrome Patients Condition: Mucopolysaccharidosis II Date: 2011-02-22 Interventions:
|
Recruiting |
Study Name: The Long-term Safety Study of Idursulfase-beta in Hunter Syndrome(Mucopolysaccharidosis II) Patients Condition: Hunter Syndrome Date: 2014-01-19 |
Recruiting |
Study Name: Long-term Evaluation on Height and Weight in Patients With MPS II Who Started Treatment at < 6 Years of Age Condition: Hunter Syndrome Date: 2015-05-20 Interventions: Drug: Elaprase for intravenous (IV) infusion Patients enrolled in this study will receive once-weekly IV |
Completed |
Study Name: Collection and Study of Cerebrospinal Fluid in Patients With Hunter Syndrome Condition: Hunter Syndrome Date: 2011-10-06 Interventions: Other: No treatment |
Completed |
Study Name: An Observational Study Evaluating Anti-Idursulfase Serum Antibody Response in Hunter Syndrome Patients Condition: Hunter Syndrome Date: 2009-04-16 Interventions: Biological: Idursulfase Patients received idursulfase as prescribed by their physician following locally |
Completed |
Study Name: Iduronate-2-sulfatase Enzyme Replacement Therapy in Mucopolysaccharidosis II (MPS II) Condition: Mucopolysaccharidosis II Date: 2003-09-29 Interventions:
|
Completed |
Study Name: A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase® Condition: Hunter Syndrome Date: 2009-06-12 Interventions:
|